GenMark Diagnostics Inc. (GNMK) announced after the bell Monday that it now expects to report full year 2013 revenues of approximately $30 million, down from its original estimate of approximately $35 million. The consensus estimate is for revenues of $35.11 million.
GenMark Diagnostics gapped open lower Tuesday and fell in early trade, before settling into a range. Shares finished with a loss of 1.40 at $9.57 on above average volume. The stock sank to a 5-month low.
For comments and feedback: editorial@rttnews.com